Download presentation
Presentation is loading. Please wait.
Published byVictor Ellis Modified over 9 years ago
2
Drugs for Congestive Heart Failure
3
BACKGROUND DEFINITION: The inability of heart to meet the needs of peripheral systems. PATHOGENY: myocardium contraction & heart load SYMPTOMS: weakness, fatigue and dyspnea, cyanosis, edema.
4
Change of myocardial structure in CHF Apoptosis Extracellular matrix(ECM) fibrosis Myocardial hypertrophy and remodeling.
5
Change of myocardial function in CHF Systolic dysfunction actin-troponin-tropomyosin system ATP Ca-excitation-contraction-coupling Diastolic dysfunction compliance
6
Change of neural-endocrine system in CHF sympathetic nerve system activation renin-angiotensin-aldosterone system activation Arginine-Vasopressin Endothelin Tumor necrosis factor- α Atrial natriuretic peptide EDRF-NO Prostaglandins
7
Classification of Drugs for CHF Cardiac glycosides ACEI Diuretics Others β-R blockers CCB PDEI(phosphodiestrase inhibitor) Vasodilators
8
Cardiac Glycosides Positive inotropic effect K-Na-ATPase Na Ca Ca Effects on neural-hormone To inhibit sympathetic nerve activity To enhance vagus nerve activity Electrophysiologic effects Effects on ECG Effects on Kidney
9
Cardiac Glycosides P.K Absorption Distribution Metabolism Excretion Influencing factors
10
Cardiac Glycosides Clinic uses CHF Arrhythmia : Atrial fibrillation, Atrial flutter ADR Extracardiac Cardiac: Supra -/-Ventricular arrhythmia, Atrial Ventricular Block, ventricular premature beat Therapy: K, phenytoin sodium, lidocaine. Antibody of it.
11
Cardiac Glycosides Interactions: Antiarrhythmia Agents Digitoxin, Cediland, Strophanthin K PDEI (milrinone, amrinone, vesnarinone) ATP AC cAMP PDEI 5 ’ AMP Ca influx
12
RAS BLOCKERS ACEI (Captopril, enalapril) Mechanism a. Ang Ⅱ ( ) Hypertrophy & proliferation of myocardium & VSMC b. Afterload Antagonist of AT 1 (Losartan) BK NO ( - ) diastolic dysfunction ( + )
13
OTHERS β-R blockers β-R sensitivity RAS DIURETICS CCB proliferation LOAD Vasodilatiors
14
REVIEW & QUESTIONS The mechanisms of cardiac glycosides. The ADR of them. The classification of drugs for CHF.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.